[1]
|
Grimm PD, Blasko JC, Sylvester JE, et al. 10-year biochemical(prostate specific antigen) control of prostate cancer with 125I brachy therapy[J]. Int J Radiat Oncol Biol Phys, 2001, 51(1):31-40. |
[2]
|
Ragde H, Korb LJ, Elgamal AA, et al. Modern prostate brachytherapy:postate specific antigen results in 219 patients with up to 12years of observed follow-up[J]. Cancer, 2000, 89(1):135-141. |
[3]
|
Merrick GS, Butler WM, Galbreath RW, et al. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer[J]. Int J Radiat Oncol Biol Phys, 2001,51(1):41-48. |
[4]
|
王俊杰,黄毅,冉维强,等.经会阴超声引导放射性125I粒子组织间近距离治疗睾丸切除术后复发前列腺癌[J].肿瘤防治杂志,2003,10(8):962-964.
|
[5]
|
王俊杰,黄毅,冉维强,等.放射性粒子组织间近距离治疗肿瘤近期疗效[J].中国微创外科杂志,2003,3(1):148-149.
|
[6]
|
King CR, Dipetrillo TA, Wazer DE. Optimal radiotherapy for prostate cancer:predictions for conventional external beam, IMRT,and brachytherapy from radiobiologic models[J]. Int J Radiat Oncol Biol Phys, 2001,46(1):165-172. |
[7]
|
王俊杰,黄毅,冉维强,等.放射性粒子组织间近距离治疗肿瘤[M].第2版,北京:北京大学医学出版社,2004.20-24.
|
[8]
|
Mitchell CR, Folkard M, Joiner MC. Effects of exposure to lowdose-rate 60Co gamma rays on human tumor sells in vitro[J]. Radiat Res, 2002, 158(3):311-318. |
[9]
|
Deweese TL, shipman JM, Dillehay LE, et al. Sensitivity of human prostatic carcinoma cell lines to low close rate radiation exposure[J]. J Wrol, 1998, 159(5):591-597. |
[10]
|
Kroger LA, Denardo GL, Gumer PH, et al. Apoptosis-related gene and protein expression in human lymphoma xenografts(Raji) after low dose rate radiation using 67 Cu-217-BAT-Lym-l radioimmunotherapy[J]. Cancer Biother Radiopharm, 2001, 16(3):213-225. |
[11]
|
Szostak M J, Kaur P, Amin P, et al. Apoptosis and bcl-2 expression in prostate cancer:significance in clinical outcome after brachytheray[J]. J Urol, 2001, 165(6 Pt 1):2126-2130. |
[12]
|
于洪升,黄从合,.低剂量辐射对肿瘤细胞凋亡、细胞周期以及凋亡相关蛋白bcl-2的影响[J].中华放射医学与防护杂志,2003,23(3):171-173.
|
[13]
|
Armpilia CI, Dale RG, Coles IP, et al. The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy in plants[J]. Int J Radiat Oncol Biol Phys, 2003, 55(2):378-385. |
[14]
|
Dicker AP, Lincc J, Leeper DB, et al. Isotope selection for permanent prostate implants. An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry[J]. Semin Urol Oncol, 2000,18(2):152-159. |
[15]
|
Yacoub A, Mckinstry R, Hinman D, et al. Epidermal growth factor and ionizing radiation up-regulate the DNA repair gengs XRCC1and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling[J]. Radiat Res, 2003, 159(2):439-452. |